Charles J. Link

4.0k total citations
99 papers, 2.6k citations indexed

About

Charles J. Link is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Charles J. Link has authored 99 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 31 papers in Genetics and 28 papers in Oncology. Recurrent topics in Charles J. Link's work include Virus-based gene therapy research (28 papers), Cancer Research and Treatments (18 papers) and Tryptophan and brain disorders (18 papers). Charles J. Link is often cited by papers focused on Virus-based gene therapy research (28 papers), Cancer Research and Treatments (18 papers) and Tryptophan and brain disorders (18 papers). Charles J. Link collaborates with scholars based in United States, Malaysia and Philippines. Charles J. Link's co-authors include Nicholas N. Vahanian, Robert B. Mandell, David H. Munn, Mario R. Mautino, Thomas A. Raffin, Benjamin Movsas, Alan H. Epstein, Elise C. Kohn, John Levy and Vilhelm A. Bohr and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Charles J. Link

99 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles J. Link United States 26 1.0k 806 570 448 418 99 2.6k
Akihiro Nawa Japan 33 1.5k 1.5× 1.5k 1.8× 649 1.1× 240 0.5× 264 0.6× 111 3.8k
Hatem Soliman United States 32 780 0.8× 1.9k 2.3× 1.2k 2.1× 229 0.5× 362 0.9× 136 3.3k
Kiyosumi Shibata Japan 41 2.1k 2.1× 2.2k 2.7× 1.0k 1.8× 241 0.5× 424 1.0× 195 5.9k
Nicolas van Baren Belgium 32 2.1k 2.1× 2.3k 2.8× 2.9k 5.1× 199 0.4× 470 1.1× 54 4.9k
Elieser Gorelik United States 31 1.7k 1.7× 1.6k 2.0× 1.9k 3.3× 222 0.5× 69 0.2× 55 4.6k
Makio Iwashima United States 24 1.2k 1.2× 874 1.1× 3.2k 5.7× 200 0.4× 174 0.4× 55 4.4k
Ate G.J. van der Zee Netherlands 35 1.5k 1.5× 1.0k 1.3× 373 0.7× 344 0.8× 47 0.1× 63 3.8k
Connie L. Finstad United States 29 927 0.9× 856 1.1× 527 0.9× 152 0.3× 37 0.1× 51 2.3k
Yumei Leng United States 22 2.4k 2.4× 821 1.0× 690 1.2× 308 0.7× 47 0.1× 27 4.0k
Dennis Way United States 21 612 0.6× 632 0.8× 377 0.7× 108 0.2× 119 0.3× 41 2.2k

Countries citing papers authored by Charles J. Link

Since Specialization
Citations

This map shows the geographic impact of Charles J. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles J. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles J. Link more than expected).

Fields of papers citing papers by Charles J. Link

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles J. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles J. Link. The network helps show where Charles J. Link may publish in the future.

Co-authorship network of co-authors of Charles J. Link

This figure shows the co-authorship network connecting the top 25 collaborators of Charles J. Link. A scholar is included among the top collaborators of Charles J. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles J. Link. Charles J. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jinjin, et al.. (2017). Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses. PLoS ONE. 12(8). e0182683–e0182683. 4 indexed citations
2.
Mandell, Robert B., Alexander N. Freiberg, Michael R. Holbrook, et al.. (2009). A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge. Virology. 397(1). 187–198. 62 indexed citations
3.
Rossi, Gabriela R., et al.. (2008). Allogeneic Melanoma Vaccine Expressing αGal Epitopes Induces Antitumor Immunity to Autologous Antigens in Mice Without Signs of Toxicity. Journal of Immunotherapy. 31(6). 545–554. 15 indexed citations
4.
Rossi, Gabriela R., Robert C. Unfer, Tatiana Seregina, & Charles J. Link. (2005). Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing α(1,3)galactosyl epitopes. Cancer Immunology Immunotherapy. 54(10). 999–1009. 27 indexed citations
5.
Link, Charles J., Nicholas N. Vahanian, & Suming Wang. (2003). Herpes Simplex Amplicon Vectors. Humana Press eBooks. 76. 61–88. 3 indexed citations
6.
Shackelford, Rodney E., et al.. (2003). Desferrioxamine treatment increases the genomic stability of Ataxia-telangiectasia cells. DNA repair. 2(9). 971–981. 20 indexed citations
7.
Link, Charles J., et al.. (2003). Transduction of hematopoietic stem cells with a retroviral vector expressing the neomycin phosphotransferase gene. Bone Marrow Transplantation. 32(S1). S33–S35. 1 indexed citations
8.
9.
Link, Charles J., et al.. (2002). Eliciting Hyperacute Rejection as a Tumor Killing Strategy. Advances in experimental medicine and biology. 465. 217–227. 3 indexed citations
10.
Mandell, Robert B., et al.. (1999). Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.. PubMed. 59(3). 661–8. 213 indexed citations
11.
Panchal, Rekha G., Suming Wang, John McDermott, & Charles J. Link. (1999). Partial Functional Correction of Xeroderma Pigmentosum Group A Cells by Suppressor tRNA. Human Gene Therapy. 10(13). 2209–2219. 31 indexed citations
12.
Link, Charles J., Ann Traynor, Tatiana Seregina, & Richard K. Burt. (1999). Adoptive Immunotherapy for Leukemia: Donor Lymphocytes Transduced with the Herpes Simplex Thymidine Kinase Gene. Cancer treatment and research. 101. 369–375. 5 indexed citations
13.
Mazo, Ilya, et al.. (1999). [28] Retroviral expression of green fluorescent protein. Methods in enzymology on CD-ROM/Methods in enzymology. 302. 329–341. 3 indexed citations
14.
Movsas, Benjamin, Thomas A. Raffin, Alan H. Epstein, & Charles J. Link. (1997). Pulmonary Radiation Injury. CHEST Journal. 111(4). 1061–1076. 230 indexed citations
15.
Levy, John, et al.. (1996). Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nature Biotechnology. 14(5). 610–614. 84 indexed citations
16.
Link, Charles J., Gisele Sarosy, Elise C. Kohn, et al.. (1995). Cutaneous manifestations of taxol® therapy. Investigational New Drugs. 13(3). 261–263. 12 indexed citations
17.
Link, Charles J. & Vilhelm A. Bohr. (1995). 3″-Azido-3′-Deoxythymidine and 2′,3′-Dideoxycytidine Do Not Inhibit Gene-Specific DNA Repair in Hamster Cells. Biochemical and Biophysical Research Communications. 208(1). 198–203. 1 indexed citations
18.
Link, Charles J., et al.. (1995). Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells. Carcinogenesis. 16(5). 1149–1155. 31 indexed citations
19.
Link, Charles J., Jay H. Robbins, & Vilhelm A. Bohr. (1995). Gene specific DNA repair of damage induced in familial Alzheimer disease cells by ultraviolet irradiation or by nitrogen mustard. Mutation Research/DNA Repair. 336(2). 115–121. 7 indexed citations
20.
Burt, Richard K., Miriam C. Poirier, Charles J. Link, & Vilhelm A. Bohr. (1991). Antineoplastic drug resistance and DNA repair. Annals of Oncology. 2(5). 325–334. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiro Nawa Breakdown of academic impact, for papers by Hatem Soliman Breakdown of academic impact, for papers by Kiyosumi Shibata Breakdown of academic impact, for papers by Nicolas van Baren Breakdown of academic impact, for papers by Elieser Gorelik Breakdown of academic impact, for papers by Makio Iwashima Breakdown of academic impact, for papers by Ate G.J. van der Zee Breakdown of academic impact, for papers by Connie L. Finstad Breakdown of academic impact, for papers by Yumei Leng Breakdown of academic impact, for papers by Dennis Way
Rankless by CCL
2026